A Meta-Analysis of Reference Values of Leptin Concentration in Healthy Postmenopausal Women

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Zhou, Xi ^a,b   Chai, YanLan ^a   Chen, Ke ^a   Yang, YunYi ^a   Liu, Zi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; PROTEIN POLYMORPHISM; REFERENCE VALUE; SAMPLE SIZE;

AGED; AGED, 80 AND OVER; AGING; BODY MASS INDEX; FEMALE; HEALTH; HORMONE REPLACEMENT THERAPY; HUMANS; LEPTIN; MIDDLE AGED; POSTMENOPAUSE; PUBLICATION BIAS; REFERENCE VALUES;

EID: 84883334505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072734     Document Type: Article

References (84)

1. Cheung WW, Mao P, (2012) Recent advances in obesity: genetics and beyond. ISRN Endocrinol 2012: 536905.
2. Stunkard AJ, Foch TT, Hrubec Z, (1986) A twin study of human obesity. JAMA 256: 51-54.
3. Hjelmborg J, Fagnani C, Silventoinen K, McGue M, Korkeila M, et al. (2008) Genetic influences on growth traits of BMI: a longitudinal study of adult twins. Obesity (Silver Spring) 16: 847-852.
4. Scherer T, Lehnert H, Hallschmid M, (2013) Brain insulin and leptin signaling in metabolic control: from animal research to clinical application. Endocrinol Metab Clin North Am 42: 109-125.
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
6. Pralong FP, Gonzales C, Voirol MJ, Palmiter RD, Brunner HR, et al. (2002) The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J 16: 712-714.
7. Carlton ED, Demas GE, French SS, (2012) Leptin, a neuroendocrine mediator of immune responses, inflammation, and sickness behaviors. Horm Behav 62: 272-279.
8. Procaccini C, Lourenco EV, Matarese G, La Cava A, (2009) Leptin signaling: A key pathway in immune responses. Curr Signal Transduct Ther 4: 22-30.
9. Oswal A, Yeo G, (2010) Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring) 18: 221-229.
10. Leibel RL (2002) The role of leptin in the control of body weight. Nutr Rev 60: S15-19; discussion S68-84, 85-17.
11. Shanley LJ, Irving AJ, Harvey J, (2001) Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci 21: RC186.
12. Ray A, (2012) Adipokine leptin in obesity-related pathology of breast cancer. J Biosci 37: 289-294.
13. Sayakhot P, Vincent A, Teede H, (2012) Breast cancer and menopause: perceptions of diagnosis, menopausal therapies and health behaviors. Climacteric 15: 59-67.
14. Thompson KJ, Lau KN, Johnson S, Martinie JB, Iannitti DA, et al. (2011) Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling. HPB (Oxford) 13: 225-233.
15. Wang SN, Lee KT, Ker CG, (2010) Leptin in hepatocellular carcinoma. World J Gastroenterol 16: 5801-5809.
16. Saxena NK, Sharma D, Ding X, Lin S, Marra F, et al. (2007) Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67: 2497-2507.
17. Ptak A, Kolaczkowska E, Gregoraszczuk EL, (2012) Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine43: 394-403.
18. Uddin S, Bu R, Ahmed M, Abubaker J, Al-Dayel F, et al. (2009) Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol Cancer 8: 74.
19. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
20. Hedges LV, Olkin I, Statistiker M (1985) Statistical methods for meta-analysis. Academic Press New York.
21. Hedges LV, Vevea JL, (1998) Fixed-and random-effects models in meta-analysis. Psychol Methods 3: 486.
22. Larsson H, Elmstahl S, Ahren B, (1996) Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 45: 1580-1584.
23. Haffner SM, Mykkanen L, Stern MP, (1997) Leptin concentrations in women in the San Antonio Heart Study: Effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol 146: 581-585.
24. Goulding A, Taylor RW, (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63: 456-458.
25. Hadji P, Gorke K, Hars O, Bauer T, Emons G, et al. (2000) The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women. Maturitas 37: 105-111.
26. Hadji P, Hars O, Bock K, Sturm G, Bauer T, et al. (2000) The influence of menopause and body mass index on serum leptin concentrations. Eur J Endocrinol 143: 55-60.
27. Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, et al. (2002) Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87: 1030-1035.
28. Douchi T, Iwamoto I, Yoshimitsu N, Kosha S, Nagata Y, (2002) Leptin production in pre- and postmenopausal women. Maturitas 42: 219-223.
29. Hadji P, Bock K, Gotschalk M, Hars O, Backhus J, et al. (2003) The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas 44: 141-148.
30. Lambrinoudaki I, Christodoulakos G, Panoulis C, Botsis D, Rizos D, et al. (2003) Determinants of serum leptin levels in healthy postmenopausal women. J Endocrinol Invest 26: 1225-1230.
31. Munoz J, Gower BA, (2003) Relationship between serum leptin concentration and low-density muscle in postmenopausal women. J Clin Endocrinol Metab 88: 1157-1161.
32. Sahin G, Polat G, Baethis S, Milcan A, Baethdatoethlu O, et al. (2003) Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Rheumatol Int 23: 87-91.
33. Shaarawy M, Abassi AF, Hassan H, Salem ME, (2003) Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Fertil Steril 79: 919-924.
34. Ushiroyama T, Ikeda A, Hosotani T, Higashiyama T, Ueki M, (2003) Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women. Gynecol Endocrinol 17: 31-36.
35. Cordero-MacIntyre ZR, Metghalchi S, Rosen J, Peters W, Lohman TG, et al. (2004) Impact of weight loss on serum leptin in obese postmenopausal women. J Appl Res 4: 60-67.
36. Ayub N, Khan SR, Syed F, (2006) Leptin levels in pre and post menopausal Pakistani women. J Pak Med Assoc 56: 3-5.
37. Jaleel F, Jaleel A, Rahman MA, Alam E, (2006) Comparison of adiponectin, leptin and blood lipid levels in normal and obese postmenopausal women. J Pak Med Assoc 56: 391-394.
38. Rolland YM, Perry HM III, Patrick P, Banks WA, Morley JE, (2006) Leptin and adiponectin levels in middle-aged postmenopausal women: associations with lifestyle habits, hormones, and inflammatory markers-a cross-sectional study. Metabolism 55: 1630-1636.
39. Meyers JA, Liu AY, McTiernan A, Wener MH, Wood B, et al. (2008) Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women. J Endocrinol 199: 51-60.
40. Khokhar KK, Sidhu S, Kaur G, (2010) Correlation between leptin level and hypertension in normal and obese pre- and postmenopausal women. Eur J Endocrinol 163: 873-878.
41. Wu X-Y, Wu X-P, Luo X-H, Xie H, Zhang H, et al. (2010) The relationship between the levels of gonadotropic hormones and OPG, leptin, TGF-beta 1 and TGF-beta 2 in Chinese adult women. Clinica Chimica Acta 411: 1296-1305.
42. Kristensen K, Pedersen SB, Vestergaard P, Mosekilde L, Richelsen B, (1999) Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 163: 55-62.
43. Cagnacci A, Malmusi S, Arangino S, Zanni A, Rovati L, et al. (2002) Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. Menopause (New York, NY) 9: 65-71.
44. Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, et al. (2004) Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause (New York, NY) 11: 466-473.
45. Carlo C, Tommaselli GA, Spiezio Sardo A, Sammartino A, Attianese W, et al. (2007) Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women. Menopause (New York, NY) 11: 450-454.
46. Soni AC, Conroy MB, MacKey RH, Kuller LH, (2011) Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women. Menopause 18: 296-301.
47. Di Carlo C, Tommaselli GA, Pisano G, Nasti A, Rossi V, et al. (2000) Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause (New York, NY) 7: 36-41.
48. Bednarek-Tupikowska G, Filus A, Kuliczkowska-Plaksej J, Tupikowski K, Bohdanowicz-Pawlak A, et al. (2006) Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy. Gynecol Endocrinol 22: 207-212.
49. Ren RX, Shen Y, (2010) A meta-analysis of relationship between birth weight and cord blood leptin levels in newborns. World J Pediatr 6: 311-316.
50. Rozenberg S, Vandromme J, Antoine C, (2013) Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol 9: 216-227.
51. Simon JA, (2010) Postmenopausal hormone therapy: risks versus benefits reassessed. Nat Rev Endocrinol 6: 661-663.
52. Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, et al. (2009) Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol 170: 12-23.
53. Banks E, Canfell K, (2009) Invited Commentary: Hormone therapy risks and benefits-The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am J Epidemiol 170: 24-28.
54. van Staa TP, Cooper C, Barlow D, Leufkens HG, (2008) Individualizing the risks and benefits of postmenopausal hormone therapy. Menopause 15: 374-381.
55. Manson JE, (2013) The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy. Metabolism 62Suppl 1: S15-19.
56. MacKay NJ, (2010) Scaling of human body mass with height: the body mass index revisited. J Biomech 43: 764-766.
57. Flegal KM, Troiano RP, Ballard-Barbash R, (2001) Aim for a healthy weight: what is the target? J Nutr 131: 440S-450S.
58. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, et al. (1997) Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 3: 575-579.
59. Licinio J, Negrao AB, Mantzoros C, Kaklamani V, Wong ML, et al. (1998) Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab 83: 4140-4147.
60. Vila R, Adan C, Rafecas I, Fernandez-Lopez JA, Remesar X, et al. (1998) Plasma leptin turnover rates in lean and obese Zucker rats. Endocrinology 139: 4466-4469.
61. Price TO, Farr SA, Yi X, Vinogradov S, Batrakova E, et al. (2010) Transport across the blood-brain barrier of pluronic leptin. J Pharmacol Exp Ther 333: 253-263.
62. Langendonk JG, Pijl H, Toornvliet AC, Burggraaf J, Frolich M, et al. (1998) Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab 83: 1706-1712.
63. Koutkia P, Canavan B, Johnson ML, DePaoli A, Grinspoon S, (2003) Characterization of leptin pulse dynamics and relationship to fat mass, growth hormone, cortisol, and insulin. Am J Physiol Endocrinol Metab 285: E372-379.
64. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, et al. (1997) Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 82: 561-565.
65. Bergendahl M, Iranmanesh A, Evans WS, Veldhuis JD, (2000) Short-term fasting selectively suppresses leptin pulse mass and 24-hour rhythmic leptin release in healthy midluteal phase women without disturbing leptin pulse frequency or its entropy control (pattern orderliness). J Clin Endocrinol Metab 85: 207-213.
66. Hancox RJ, Landhuis CE, (2011) Correlation between measures of insulin resistance in fasting and non-fasting blood. Diabetol Metab Syndr 3: 23.
67. Yildiz BO, Haznedaroglu IC, (2006) Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int J Biochem Cell Biol 38: 820-830.
68. Friedman JM (2002) The function of leptin in nutrition, weight, and physiology. Nutr Rev 60: S1-14; discussion S68-84, 85-17.
69. Himms-Hagen J, (1999) Physiological roles of the leptin endocrine system: differences between mice and humans. Crit Rev Clin Lab Sci 36: 575-655.
70. Fliedner S, Schulz C, Lehnert H, (2006) Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 147: 2088-2094.
71. Chahal HS, Drake WM, (2007) The endocrine system and ageing. J Pathol 211: 173-180.
72. Taylor GT, Bardgett M, Farr S, Womack S, Komitowski D, et al. (1993) Steroidal interactions in the ageing endocrine system: absence of suppression and pathology in reproductive systems of old males from a mixed-sex socially stressful rat colony. J Endocrinol 137: 115-122.
73. Coylewright M, Reckelhoff JF, Ouyang P, (2008) Menopause and hypertension: an age-old debate. Hypertension 51: 952-959.
74. Rappelli A (2002) Hypertension and obesity after the menopause. J Hypertens Suppl 20: S26-28.
75. Britt K, (2012) Menarche, menopause, and breast cancer risk. Lancet Oncol 13: 1071-1072.
76. Casadesus G, Rolston RK, Webber KM, Atwood CS, Bowen RL, et al. (2008) Menopause, estrogen, and gonadotropins in Alzheimer's disease. Adv Clin Chem 45: 139-153.
77. Davey DA, (2012) Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause. Womens Health (Lond Engl) 8: 169-189.
78. Hinds L, Price J, (2010) Menopause, hormone replacement and gynaecological cancers. Menopause Int 16: 89-93.
79. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, (2012) Trial does not change the conclusions of Cochrane review of long term hormone therapy for perimenopausal and postmenopausal women. BMJ 345: e8141.
80. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, (2012) Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 7: CD004143.
81. Nagy TR, Gower BA, Trowbridge CA, Dezenberg C, Shewchuk RM, et al. (1997) Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children. J Clin Endocrinol Metab 82: 2148-2152.
82. Venner AA, Doyle-Baker PK, Lyon ME, Fung TS, (2009) A meta-analysis of leptin reference ranges in the healthy paediatric prepubertal population. Ann Clin Biochem 46: 65-72.
83. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS, (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152: 93-100.
84. Brennan AM, Mantzoros CS, (2006) Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nat Clin Pract Endocrinol Metab 2: 318-327.